- CVS Health (NYSE:CVS) fell 3.6% in today's trade after the U.S. Department of Justice said in a court filing that a partial government shutdown could delay its response to comments on the company's purchase of Aetna, a necessary step in giving final approval to the deal.
- Judge Leon of the D.C. District Court has been reviewing a consent decree reached by the government and the companies in October to allow the merger; the DoJ also is required to respond to public comments on the consent agreement.
- The DoJ said in a court filing that a lapse in funding as of midnight on Jan. 4 meant that its Antitrust Division could not process the comments until its appropriations were restored.